We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+32.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$703M
AUM Growth
+$202M
Cap. Flow
+$117M
Cap. Flow %
16.67%
Top 10 Hldgs %
43.13%
Holding
134
New
60
Increased
28
Reduced
13
Closed
31

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$12.9M
2
XRAY icon
Dentsply Sirona
XRAY
+$9.25M
3
BSX icon
Boston Scientific
BSX
+$7.14M
4
VRAY
ViewRay, Inc.
VRAY
+$7.09M
5
GILD icon
Gilead Sciences
GILD
+$6.65M

Top Sells

Rank Stock Value
1
SIBN icon
SI-BONE Inc
SIBN
+$4.49M
2
AMGN icon
Amgen
AMGN
+$3.89M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.33M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$2.99M
5
AMRN
Amarin Corp
AMRN
+$2.78M

Sector Composition

Rank Sector Weight
1 Healthcare 36.29%
2 Industrials 0.63%
3 Financials 0.27%
4 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTNT
76
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.97M 0.28%
+5,467
New +$1.92M
PTLA
77
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.95M 0.28%
56,225
+6,225
+12% +$180K
STAA icon
78
CALL
STAAR Surgical
STAA
$1.24B
$1.92M 0.27%
+56,200
New +$1.99M
EHTH icon
79
eHealth
EHTH
$39.1M
$1.87M 0.27%
+30,000
New +$1.65M
ARQL
80
DELISTED
Arqule Inc
ARQL
$1.84M 0.26%
383,500
+311,532
+433% +$1.2M
ADMA icon
81
PUT
ADMA Biologics
ADMA
$2.22B
$1.81M 0.26%
+477,800
New +$1.69M
DXCM icon
82
CALL
DexCom
DXCM
$33.8B
$1.79M 0.25%
+60,000
New +$2.11M
SIEN
83
CALL
DELISTED
Sientra, Inc.
SIEN
$1.72M 0.24%
+20,000
New +$2.24M
SIEN
84
DELISTED
Sientra, Inc.
SIEN
$1.63M 0.23%
+19,043
New +$2.13M
SAGE
85
DELISTED
Sage Therapeutics
SAGE
$1.59M 0.23%
+10,000
New +$1.45M
BHVN
86
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.54M 0.22%
+30,000
New +$1.3M
IMGN
87
CALL
DELISTED
Immunogen Inc
IMGN
$1.42M 0.2%
524,600
+31,200
+6% +$135K
VRAY
88
CALL
DELISTED
ViewRay, Inc.
VRAY
$1.25M 0.18%
168,700
+18,700
+12% +$144K
ITCI
89
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.22M 0.17%
+100,000
New +$1.28M
MRSN
90
DELISTED
Mersana Therapeutics
MRSN
$1.04M 0.15%
+7,877
New +$991K
QTNT
91
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.01M 0.14%
+2,813
New +$990K
CPRX
92
DELISTED
Catalyst Pharmaceutical
CPRX
$1.01M 0.14%
197,594
+17,396
+10% +$51.1K
PBYI icon
93
CALL
Puma Biotechnology
PBYI
$453M
$718K 0.1%
+18,500
New +$565K
KPTI icon
94
Karyopharm Therapeutics
KPTI
$47.6M
$584K 0.08%
+6,667
New +$739K
VTGN icon
95
VistaGen Therapeutics
VTGN
$11.9M
$544K 0.08%
+14,167
New +$618K
TGTX icon
96
TG Therapeutics
TGTX
$7.64B
$520K 0.07%
+64,719
New +$350K
IIN
97
DELISTED
IntriCon Corporation
IIN
$502K 0.07%
+20,000
New +$508K
CLVS
98
DELISTED
Clovis Oncology, Inc.
CLVS
$496K 0.07%
+20,000
New +$501K
STML
99
DELISTED
Stemline Therapeutics, Inc.
STML
$489K 0.07%
+38,084
New +$431K
QURE icon
100
uniQure
QURE
$3.12B
$440K 0.06%
+7,370
New +$329K
2 3
4
5 6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2019 Portfolio in Review

As of Q1 2019, Pura Vida Investments held 134 positions worth $703M, up 40% from $501M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments deployed $117M of net new capital in Q1 2019, opening 60 new positions and adding to 28 existing holdings. Its largest new stake was Zimmer Biomet: 113,300 shares worth $14M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $2.99M trimmed.

  • Pura Vida Investments's largest Q1 2019 buy was Zimmer Biomet: 113,300 shares worth $14M.
  • Pura Vida Investments added most to Boston Scientific in Q1 2019, an estimated $7.14M increase.
  • Pura Vida Investments's biggest Q1 2019 reduction was Tandem Diabetes Care, cutting an estimated $2.99M.
  • Pura Vida Investments fully exited SI-BONE Inc in Q1 2019, selling an estimated $4.49M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $703M portfolio in Q1 2019.
  • Pura Vida Investments opened 60 new positions and closed 31 in Q1 2019.
  • Pura Vida Investments's portfolio value rose 40% quarter-over-quarter to $703M.

Based on Pura Vida Investments's 13F filing for Q1 2019, filed 14 May 2019.